Encore Global Management, LP

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 2135356 HOUSTON, TX

Position in REGN

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$3,148,877

+$2,298,973 QoQ

Shares Held

5,050

+359.1% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

3.09%

of 13F equity value

Holder Rank

#450

of 1,320 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Encore Global Management, LP holds $6,082,178 across 5 Biotechnology names. REGN ranks #1 (51.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc. This page	5,050	$3,148,877
2	CRSP	CRISPR Therapeutics AG	30,557	$1,666,578
3	CYTK	Cytokinetics Inc	12,731	$1,084,553
4	RPRX	Royalty Pharma plc	2,000	$112,140
5	MRNA	Moderna, Inc.	1,000	$70,030

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,148,877	5,050	+359.1%	Shares	Sole	2026-08-11
2026-03-31	$849,904	1,100	—	Shares	Sole	2026-05-18
No filing history on record for this holder in this stock.